Home Stock

Stock Research: NATCO Pharma

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

NATCO Pharma

NSEI:NATCOPHARM INE987B01026
41
  • Value
    53
  • Growth
    1
  • Safety
    Safety
    96
  • Combined
    46
  • Sentiment
    40
  • 360° View
    360° View
    41
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Natco Pharma Limited is an India-based vertically integrated pharmaceutical company focused on research and development, manufacturing, and commercialization of complex pharmaceuticals. It operates in Pharmaceuticals and Agro chemicals, specializing in catering to niche markets and offering solutions for complex medical needs. It has nine manufacturing facilities across India and two research centers in Telangana, selling products to international markets such as Brazil, Europe, and the United States of America. In the last fiscal year, the company had a market cap of $2128 million, profits of $438 million, and revenue of $518 million.

more
Strongest Rank Growth
Weakest Rank Safety
Country India
Industry Pharmaceuticals
Size Small
Website natcopharma.co.in
Index
SDG 1
SDG 2
SDG 3
SDG 4
NATCO Pharma stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
53 85 83 75
Growth
1 69 100 33
Safety
Safety
96 91 97 77
Sentiment
40 53 92 10
360° View
360° View
41 99 100 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
13 23 40 19
Opinions Change
87 21 50 50
Pro Holdings
n/a 70 100 44
Market Pulse
39 62 85 37
Sentiment
40 53 92 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
53 85 83 75
Growth
1 69 100 33
Safety Safety
96 91 97 77
Combined
46 100 100 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
76 100 100 76
Price vs. Earnings (P/E)
31 58 61 41
Price vs. Book (P/B)
74 78 78 65
Dividend Yield
45 69 66 72
Value
53 85 83 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
1 74 84 100
Profit Growth
8 76 90 26
Capital Growth
4 69 81 31
Stock Returns
13 23 75 31
Growth
1 69 100 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
78 60 74 66
Refinancing
85 80 84 74
Liquidity
86 80 68 65
Safety Safety
96 91 97 77

Similar Stocks

Discover high‑ranked alternatives to NATCO Pharma and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews